Monopar Therapeutics Inc. MNPR
Set alert
66.28 USD -4.04 -5.75%
At close · Nov 2
66.28 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
65.01 Day range 70.26
50.07 52-week range 124.82
- YTD
- +1.50%
- 1 year
- -23.07%
- Open
- 70.02
- Prev close
- 70.32
- Mkt cap
- 444.88M
- Vol
- 218.90K
- Avg vol
- 171.66K
- EPS
- -2.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 65.01
- High
- 70.26
- Forward P/E
- -10.17
- Beta
- 1.10
- Short ratio
- 0.15
- Inst. own
- 24.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 17.85
- 200-d avg
- 7.12
- 1y target
- 27.33
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 2026 | 19 hours ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 9, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
Analyst view
Consensus: none
Price target (mean) 27.33 -58.8% downside
Now 66.28
- Target (low)
- 22.00
- Target (mean)
- 27.33
- Target (high)
- 37.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.42 | -0.63 – -0.29 | -0.60 | +30.0% | 0 | 0.0% | 3 |
| Next quarter | -0.54333 | -0.71 – -0.35 | -0.50 | -8.7% | 0 | 0.0% | 3 |
| Current year | -1.77 | -2.02 – -1.62 | -3.05 | +41.9% | 0 | 0.0% | 3 |
| Next year | -2.68 | -4.16 – -1.48 | -1.77 | -51.3% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 11, 2024 | JonesTrading | Upgrade | Hold | Buy |
| Jun 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 15, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 29, 2023 | Maxim Group | Downgrade | Buy | Hold |
| Mar 28, 2023 | EF Hutton | Maintained | — | Buy |
| Mar 24, 2023 | EF Hutton | Reiterated | — | Buy |
| Feb 15, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 14, 2023 | EF Hutton | Reiterated | — | Buy |
| Jan 23, 2023 | EF Hutton | Initiated | — | Buy |
| Aug 16, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 1, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Jan 28, 2021 | Roth Capital | Initiated | — | Buy |
| Sep 24, 2020 | Maxim Group | Initiated | — | Buy |
| Feb 19, 2020 | Brookline Capital | Initiated | — | Buy |
| Feb 3, 2020 | JonesTrading | Initiated | — | Buy |